Sandoz inks $275M settlement in generic antitrust litigation
Sandoz has agreed to pay $275 million to settle multidistrict generic price-fixing claims brought by a group that includes some insurers …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
